These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6347034)

  • 1. Oral physostigmine and lecithin improve memory in Alzheimer disease.
    Thal LJ; Fuld PA; Masur DM; Sharpless NS
    Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physostigmine and lecithin on memory in Alzheimer disease.
    Peters BH; Levin HS
    Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease.
    Thal LJ; Masur DM; Sharpless NS; Fuld PA; Davies P
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):627-36. PubMed ID: 3797688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved verbal learning after outpatient oral physostigmine therapy in patients with dementia of the Alzheimer type.
    Sevush S; Guterman A; Villalon AV
    J Clin Psychiatry; 1991 Jul; 52(7):300-3. PubMed ID: 2071560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outpatient treatment of senile dementia with oral physostigmine.
    Beller SA; Overall JE; Rhoades HM; Swann AC
    J Clin Psychiatry; 1988 Oct; 49(10):400-4. PubMed ID: 3049561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term administration of oral physostigmine and lecithin improve memory in Alzheimer's disease.
    Levin HS; Peters BH
    Ann Neurol; 1984 Feb; 15(2):210. PubMed ID: 6703661
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
    Volger BW
    Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients.
    Levin HS; Peters BH; Kalisky Z; High WM; von Laufen A; Eisenberg HM; Morrison DP; Gary HE
    Cent Nerv Syst Trauma; 1986; 3(4):333-42. PubMed ID: 3555852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug combination may improve memory.
    Geriatrics; 1979 Oct; 34(10):15. PubMed ID: 478303
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of oral physostigmine in Alzheimer's disease.
    Stern Y; Sano M; Mayeux R
    Ann Neurol; 1987 Sep; 22(3):306-10. PubMed ID: 3674795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory decline in the aged: treatment with lecithin and physostigmine.
    Drachman DA; Glosser G; Fleming P; Longenecker G
    Neurology; 1982 Sep; 32(9):944-50. PubMed ID: 6287359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine.
    Asthana S; Raffaele KC; Berardi A; Greig NH; Haxby JV; Schapiro MB; Soncrant TT
    Alzheimer Dis Assoc Disord; 1995; 9(4):223-32. PubMed ID: 8749612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral physostigmine and lecithin improve memory in Alzheimer's disease.
    Thal LJ; Fuld PA; Masur DM; Sharpless NS; Davies P
    Psychopharmacol Bull; 1983; 19(3):454-6. PubMed ID: 6635124
    [No Abstract]   [Full Text] [Related]  

  • 17. Cortisol responses to cholinergic drugs in Alzheimer's disease.
    Kumar V; Smith RC; Sherman KA; Ashford W; Murphy J; Giacobini E; Colliver J
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):471-6. PubMed ID: 3069749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
    Davis KL; Mohs RC
    Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
    Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S
    J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of long term high-dose lecithin to retard progression of early-onset Alzheimer's disease.
    Heyman A; Schmechel D; Wilkinson W; Rogers H; Krishnan R; Holloway D; Schultz K; Gwyther L; Peoples R; Utley C
    J Neural Transm Suppl; 1987; 24():279-86. PubMed ID: 3479525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.